Study blood samples and tiny cell particles in breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing to sign the study consent form
- Be female
- Have a confirmed breast cancer diagnosis with a plan for surgery or (in some cases) chemotherapy
- If your cancer is early, you should have no distant spread and not be scheduled for chemotherapy before surgery
- If your cancer is metastatic, you should be able to receive systemic (whole-body) chemotherapy and be fit for it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This trial studies small particles in the blood (called extracellular vesicles) in people receiving chemotherapy before surgery for breast cancer. It may help doctors learn more about what those particles can tell them during neoadjuvant treatment.
This study looks at tiny particles in your blood and tumor to see if they can predict how well your chemotherapy will work for breast cancer. The goal is to help guide treatment based on your individual cancer.
This study looks at blood and tissue samples from people newly diagnosed with breast cancer to better understand the disease and possibly find better ways to treat it. It is for people who have not yet started treatment, so it may be an opportunity to contribute to research early in your journey.
This study examines tiny particles in your blood from breast cancer cells to better predict which treatments will work best for you. Researchers will collect blood samples and a small tissue sample to understand your cancer's characteristics and help doctors choose more effective therapy.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.